402 related articles for article (PubMed ID: 25637587)
21. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
[TBL] [Abstract][Full Text] [Related]
22. Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months Old.
Woo EJ; Winiecki SK; Arya D; Beeler J
Pediatr Infect Dis J; 2016 Aug; 35(8):e253-7. PubMed ID: 27167117
[TBL] [Abstract][Full Text] [Related]
23. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
[TBL] [Abstract][Full Text] [Related]
24. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
Moro PL; Cragan J; Lewis P; Sukumaran L
Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
[TBL] [Abstract][Full Text] [Related]
25. Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013.
Moro PL; Zheteyeva Y; Lewis P; Shi J; Yue X; Museru OI; Broder K
Vaccine; 2015 Jan; 33(4):519-22. PubMed ID: 25500173
[TBL] [Abstract][Full Text] [Related]
26. Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018.
McNeil MM; Paradowska-Stankiewicz I; Miller ER; Marquez PL; Seshadri S; Collins LC; Cano MV
Vaccine; 2019 Oct; 37(44):6760-6767. PubMed ID: 31548014
[TBL] [Abstract][Full Text] [Related]
27. Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).
Wei L; Scott J
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):922-33. PubMed ID: 26045284
[TBL] [Abstract][Full Text] [Related]
28. Adverse events after vaccination among HIV-positive persons, 1990-2016.
Su JR; Ng C; Lewis PW; Cano MV
PLoS One; 2018; 13(6):e0199229. PubMed ID: 29920551
[TBL] [Abstract][Full Text] [Related]
29. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
Moro PL; Yue X; Lewis P; Haber P; Broder K
Vaccine; 2011 Nov; 29(50):9404-8. PubMed ID: 21920404
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
31. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
32. Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.
Myers TR; McNeil MM; Ng CS; Li R; Marquez PL; Moro PL; Omer SB; Cano MV
Vaccine; 2020 Sep; 38(40):6291-6298. PubMed ID: 32747215
[TBL] [Abstract][Full Text] [Related]
33. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
[TBL] [Abstract][Full Text] [Related]
34. Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink.
Hanson KE; Marin M; Daley MF; Groom HC; Jackson LA; Sy LS; Klein NP; DeSilva MB; Panagiotakopoulos L; Weintraub E; Belongia EA; McLean HQ
Vaccine X; 2023 Apr; 13():100268. PubMed ID: 36814595
[TBL] [Abstract][Full Text] [Related]
35. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.
Moro PL; Woo EJ; Marquez P; Cano M
Vaccine; 2020 Aug; 38(37):5923-5926. PubMed ID: 32709434
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
[TBL] [Abstract][Full Text] [Related]
38. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.
Moro PL; Arana J; Cano M; Menschik D; Yue X; Lewis P; Haber P; Martin D; Broder K
Clin Infect Dis; 2012 Jun; 54(11):1608-14. PubMed ID: 22441652
[TBL] [Abstract][Full Text] [Related]
39. Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.
Moro PL; Woo EJ; Paul W; Lewis P; Petersen BW; Cano M
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004846. PubMed ID: 27410239
[TBL] [Abstract][Full Text] [Related]
40. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
